Minerva Neurosciences (NASDAQ: NERV)
Minerva Neurosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Minerva Neurosciences Company Info
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
News & Analysis
Why Minerva Neurosciences Is Heading Higher Today
The biotech's shares are mounting a modest comeback after their ugly decline on Friday.
Here's Why Minerva Neurosciences Collapsed Today
The company's lead drug candidate flopped in a phase 3 trial. Can a longer-term follow-up study resurrect the asset?
Why Minerva Neurosciences Stock Is Cratering Today
Minerva's shares are crumbling today on the heels of a major clinical setback.
These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?
Two healthcare stocks, two plunging stock prices, and two unique scenarios heading into the end of 2019.
Here's Why Minerva Neurosciences Fell Over 28% Today
A cyberattack resulted in a clinical trial delay. Really.
Why Minerva Neurosciences Inc. Fell 31.1% in July
These two news items were the primary reasons that Minerva's stock shed nearly a third of its value last month.
Why Minerva Neurosciences Stock Is Soaring Today
Minerva Neurosciences and Johnson & Johnson have amended their co-development agreement for the experimental insomnia drug MIN-202.
Valuation
Earnings Transcripts
Minerva Neurosciences (NERV) Q4 2020 Earnings Call Transcript
NERV earnings call for the period ending December 31, 2020.
Minerva Neurosciences (NERV) Q3 2020 Earnings Call Transcript
NERV earnings call for the period ending September 30, 2020.
Minerva Neurosciences (NERV) Q2 2020 Earnings Call Transcript
NERV earnings call for the period ending June 30, 2020.
Minerva Neurosciences Inc (NERV) Q1 2020 Earnings Call Transcript
NERV earnings call for the period ending March 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.